Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05353335

Chronotherapy in Children With Chronic Kidney Disease

Investigating if Nocturnal Blood Pressure Patterns Are Modifiable in Children With Chronic Kidney Disease

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This is a pilot, crossover trial in which the investigator will determine if retiming of one anti-hypertensive medication from morning to evening can effectuate normal blood pressure dipping patterns in children and adolescents with chronic kidney disease.

Detailed description

Normally blood pressure declines by at least 10% from daytime to nighttime. In children with chronic kidney disease (CKD), often this does not happen (termed "non-dipping"). This study is a pilot, randomized cross-over trial. The main purpose of this study is to investigate whether non-dipping can be modified with retiming of anti-hypertensives in children with CKD. This is important because in adults, non-dipping has been associated with increased cardiovascular disease risk and more rapid progression of kidney disease. Thus, identification of how to modify this in children with CKD, may lead to future randomized controlled trials to evaluate whether chronotherapy improves outcomes in this population, which is at high risk for morbidity and mortality in adulthood. The primary objective of this study is to determine whether retiming of one anti-hypertensive to the evening will increase nocturnal systolic blood pressure change (%) in children with CKD, hypertension and non-dipping. The secondary objective of this study is to determine whether retiming of one anti-hypertensive to the evening will increase nocturnal diastolic blood pressure change (%) in children with CKD, hypertension and non-dipping. Another secondary objective is to determine if the proportion of subjects classified as having a non-dipping pattern is significantly lower on evening dosing of anti-hypertensives.

Conditions

Interventions

TypeNameDescription
OTHERRe-timing of anti-hypertensive drugThe intervention will consist of shifting the anti-hypertensive medication from morning/early dose to an evening/later dose
OTHERCurrent regimenThe participants will begin on their current regimen.

Timeline

Start date
2025-04-01
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2022-04-29
Last updated
2025-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05353335. Inclusion in this directory is not an endorsement.